Warning: The NCBI web site requires JavaScript to function. more...
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
Smolen JS, Aletaha D, Grisar J, Redlich K, Steiner G, Wagner O.
Arthritis Res Ther. 2008;10(3):208. Epub 2008 May 29. Review.
Related citations
Does gene expression analysis inform us in rheumatoid arthritis?
Häupl T, Stuhlmüller B, Grützkau A, Radbruch A, Burmester GR.
Ann Rheum Dis. 2010 Jan;69 Suppl 1:i37-42. Review.
Predictive markers in rapidly progressing rheumatoid arthritis.
Landewé R.
J Rheumatol Suppl. 2007 Nov;80:8-15. Review.
Genetic markers of treatment response in rheumatoid arthritis.
Wesoly J, Wessels JA, Guchelaar HJ, Huizinga TW.
Curr Rheumatol Rep. 2006 Oct;8(5):369-77. Review.
The evolution of biomarkers in rheumatoid arthritis: from clinical research to clinical care.
van den Broek T, Tesser JR, Albani S.
Expert Opin Biol Ther. 2008 Nov;8(11):1773-85. Review.
The role of biomarkers in the management of patients with rheumatoid arthritis.
Nam J, Villeneuve E, Emery P.
Curr Rheumatol Rep. 2009 Oct;11(5):371-7. Review.
[An update on diagnostic and prognostic biomarkers of early rheumatoid arthritis].
Senolt L.
Cas Lek Cesk. 2006;145(7):538-42; discussion 542-3. Review. Czech.
Unmet needs in rheumatoid arthritis.
Bykerk V.
J Rheumatol Suppl. 2009 Jun;82:42-6. Review.
The potential roles for novel biomarkers in rheumatoid arthritis assessment.
Mease PJ.
Clin Exp Rheumatol. 2011 May-Jun;29(3):567-74. Epub 2011 Jun 30. Review.
miRNAs and rheumatoid arthritis - promising novel biomarkers.
Duroux-Richard I, Jorgensen C, Apparailly F.
Swiss Med Wkly. 2011 Mar 18;141:w13175. doi: 10.4414/smw.2011.13175.
Biomarkers in rheumatologic disease: a review.
Whitt I, Reed A.
Minn Med. 2009 Sep;92(9):38-41. Review.
The role of biologicals in early rheumatoid arthritis.
Haque UJ, Bathon JM.
Best Pract Res Clin Rheumatol. 2005 Feb;19(1):179-89. Review.
Predicting the development of RA in patients with early undifferentiated arthritis.
Raza K, Filer A.
Best Pract Res Clin Rheumatol. 2009 Feb;23(1):25-36. Review.
Biomarkers for rheumatoid arthritis: making it personal.
Lindstrom TM, Robinson WH.
Scand J Clin Lab Invest Suppl. 2010 Jul;242:79-84. Review.
Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
Syversen SW, Goll GL, van der Heijde D, Landewé R, Gaarder PI, Odegård S, Haavardsholm EA, Kvien TK.
J Rheumatol. 2009 Feb;36(2):266-72.
Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
Bansard C, Lequerré T, Daveau M, Boyer O, Tron F, Salier JP, Vittecoq O, Le-Loët X.
Rheumatology (Oxford). 2009 Sep;48(9):1021-8. Epub 2009 May 29. Review.
Proteomics: applications to the study of rheumatoid arthritis and osteoarthritis.
Gobezie R, Millett PJ, Sarracino DS, Evans C, Thornhill TS.
J Am Acad Orthop Surg. 2006 Jun;14(6):325-32. Review.
Prognostic factors in rheumatoid arthritis in the era of biologic agents.
Skapenko A, Prots I, Schulze-Koops H.
Nat Rev Rheumatol. 2009 Sep;5(9):491-6. Epub 2009 Jul 28. Review.
Biomarkers for diagnosing and monitoring autoimmune diseases.
Prince HE.
Biomarkers. 2005 Nov;10 Suppl 1:S44-9. Review.
Update on biomarkers in psoriatic arthritis.
Chandran V, Gladman DD.
Curr Rheumatol Rep. 2010 Aug;12(4):288-94. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on